Donate Toggle Menu

Dr. Brian Rini’s clinical trials Q & A

Dr. Brian Rini, chief of Clinical Trials at Vanderbilt-Ingram Cancer Center (VICC) and Vice-Chair of the KCA’s Medical Steering Committee explained the benefits and nuances of clinical trial participation in a Q & A at…

Dr. Walter Stadler discussed evolving kidney cancer treatments

Dr. Walter Stadler, an oncologist at the University of Chicago and a member emeritus of the Kidney Cancer Association’s Medical Steering Committee, spoke to Targeted Oncology about updates and changes in how kidney cancer is…

PCAC member Bruce Hill featured in Cancer Today magazine

Bruce Hill, a kidney cancer patient, patient advocate, and member of the KCA’s Patient and Caregiver Advisory Council, was featured in the spring issue of Cancer Today, the American Association for Cancer Research’s quarterly magazine….

Watch our Facebook Live on clinical trial basics

Last week, the KCA hosted its very first live streaming event! The KCA’s Medical Director Sallie McAdoo, MS, CGC, moderated a Facebook Live conversation on the basics of clinical trials. To help lend expertise, two…

This month in kidney cancer research

Welcome to our new series where we take a look at what’s happening in kidney cancer each month! From treatments and clinical trials to genetic testing and government regulations, the KCA’s Medical Director, Sallie McAdoo,…

1 2 3 14